Calvin Sandra
CIK 1882909
Transactions on file
23
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Sale | 21,977 | $902.6K | +18.3% | open → |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Exer. | 6,500 | $133.0K | +137.4% | open → |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Exer. | 6,250 | $55.8K | +443.9% | open → |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Exer. | 2,500 | $56.0K | +116.8% | open → |
| 2025-01-23 | 2025-01-22 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Sale | 925 | $17.5K | +156.4% | open → |
| 2025-02-04 | 2025-02-03 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Sale | 3,348 | $67.4K | +141.4% | open → |
| 2025-02-04 | 2025-01-31 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Grant | 13,000 | $0.00 | — | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Exer. | 10,000 | $179.6K | +170.4% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Sale | 15,000 | $375.0K | +94.3% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Exer. | 15,000 | $231.9K | +214.2% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Sale | 10,000 | $250.0K | +94.3% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Sale | 9,244 | $231.1K | +94.3% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Sale | 10,000 | $250.0K | +94.3% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Exer. | 10,000 | $174.4K | +178.5% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Sale | 10,000 | $250.0K | +94.3% | open → |
| 2025-02-12 | 2025-02-11 | TVTX Travere Therapeutics, Inc. | Officer SVP, CHIEF ACCOUNTING OFFICER | Exer. | 10,000 | $162.3K | +199.3% | open → |
| 2025-12-16 | 2025-12-15 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Sale | 2,910 | $104.8K | +34.9% | open → |
| 2025-11-06 | 2025-11-04 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Sale | 67,115 | $2.42M | +34.9% | open → |
| 2025-11-06 | 2025-11-04 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Exer. | 6,250 | $55.8K | +443.9% | open → |
| 2025-11-06 | 2025-11-04 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Exer. | 12,500 | $280.0K | +116.8% | open → |
| 2025-11-06 | 2025-11-04 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Exer. | 15,000 | $412.5K | +76.6% | open → |
| 2025-11-06 | 2025-11-04 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Exer. | 17,500 | $470.4K | +80.7% | open → |
| 2025-11-06 | 2025-11-04 | TVTX Travere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | Exer. | 10,000 | $252.5K | +92.4% | open → |
